Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza for post-operative neuropathic pain
2020-001022-57Phase 4Terminated
- Sponsor
- Wojciech Zbigniew Pawlak
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Neuralgia comparing Qutenza patch with Placebo patch (2 arms). Primary endpoint: Difference in mean change from baseline in pain score. Started Aug 2020; status: terminated.
02
Drugs
capsaicin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2020-001022-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001022-57.